Ixico in 'robust' position to handle short-term Covid-19 headwinds
Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.
FTSE AIM All-Share
743.26
16:50 28/03/24
Ixico
8.10p
16:55 28/03/24
Pharmaceuticals & Biotechnology
21,366.25
17:14 28/03/24
Over the six months ending on 31 March, Ixico's revenues grew by 33% to £4.6m, while the AIM-listed group's order book came in at £15.3m and by 20 April the latter had increased to £22.5m thanks to a "significant" new contract win.
Chief executive Giulio Cerroni said: "Despite the Covid-19 headwinds, we are delighted to be able to report a seventh consecutive reporting period of greater than 20% revenue growth whilst building a record order book for the company in these unprecedented times.
"This is testament to the increasing market adoption of our proprietary technology services and the highly committed and effective teamwork demonstrated by all our staff."
Ixico also said it had closed out the first half in a strong financial position with £6.7m of cash on hand.
As of 1305 BST, Ixico shares were down 2.06% at 68.07p.